Porvair (Leatherhead, UK) has signed a technology licensing agreement with Thermo Electron Manufacturing, a division of Thermo Fisher Scientific (California, USA). Porvair has licensed its filter technology to Thermo to develop a range of life science sample preparation filters. Porvair will manufacture the products, and Thermo will distribute and market the products worldwide.
Porvair (Leatherhead, UK) has signed a technology licensing agreement with Thermo Electron Manufacturing, a division of Thermo Fisher Scientific (California, USA). Porvair has licensed its filter technology to Thermo to develop a range of life science sample preparation filters. Porvair will manufacture the products, and Thermo will distribute and market the products worldwide.
Ben Stocks, Group Chief Executive, commented: "As part of Porvair's focus on new product development, we have been working for several years with Thermo to develop a range of laboratory sample preparation products, which we are excited to see move into the commercial phase. Porvair has received a technology transfer fee and, in addition, will generate manufacturing margins and royalties on future revenues.”
In a separate agreement, Porvair has acquired Thomas Cain, a manufacturer of environmental laboratory equipment and consumables. The acquisition will be merged with Seal Analytics, a division of Porvair.
For more information please visit:
http://www.porvair-sciences.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.